Positive rumblings heard for biotech IPOs

After suffering through doldrums recently, some biotech public offerings this year have been successful and might inspire other IPOs, writes Luke Timmerman. Investments are up as more general-interest investors return to the sector, larger companies are acquiring smaller firms and Congress seems likely to broaden the scope of accelerated approvals. "The real question is, at what point do bigger funds, not just health care specialists, move in to biotech?" asks Bob Nelsen, a managing director at Arch Venture Partners.

View Full Article in:

Biotech IPOs Start to Show Some Modest Signs of Life - Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD